Close Menu

You may find more results for this query on our sister sites: GenomeWeb and Precision Oncology News.

Home › Business, Policy & Funding › Reimbursement News › Myriad Genetics Melanoma Test Gets Final LCD

Myriad Genetics Melanoma Test Gets Final LCD

Mar 14, 2019
|
staff reporter

NEW YORK (GenomeWeb)  — Medicare contractor Palmetto GBA has issued a final local coverage determination (LCD) for Myriad Genetics' myPath Melanoma test, the firm announced today.

To read the full story....

...and receive Daily News bulletins.

Already have a 360Dx or GenomeWeb account?
Login Now.

Don't have a 360Dx or GenomeWeb account?
Register for Free.

Jun
04
Featured Webinar

COVID-19 Testing, Treatment and Future Outlook

Sponsored by
Ovation

This webinar will discuss the current status of COVID-19 testing, treatment and other aspects of the current pandemic as they relate to getting this outbreak under control.  

Jul
15
Featured Webinar

Diagnostic Challenges in Cancer Immunotherapy: An Expert Panel Discussion

Sponsored by
LGC SeraCare Life Sciences

Cancer immunotherapy is an exciting new advance for the successful treatment of many forms of metastatic cancer.

What's Popular?

In Molecular Diagnostics

  1. FDA Adds At-Home Self-Collection Template to SARS-CoV-2 Emergency Use Authorization Guidance

  2. At-Home Coronavirus Tests Get Nod From FDA But Agency Proceeding With Caution

    Premium

  3. Ravgen Sues Natera Over Cell-Free DNA Genetic Testing Patents

  4. Guardant Health Prices $315M Public Offering

  5. Sema4 Forms Coronavirus Testing Alliance With Connecticut

Sponsorships

Privacy Policy.  Terms & Conditions.  .  Copyright © 2020 GenomeWeb, a business unit of Crain Communications.  All Rights Reserved.